Matt Newman
About Matt Newman
Matt Newman is the Senior Vice President of Solutions & Services at DNAnexus, where he has worked since 2023. He has a background in biochemistry and molecular biology, with previous roles at GSK, Air Products, and QIAGEN, and possesses expertise in bioinformatics and genetic analysis.
Current Role at DNAnexus
Matt Newman serves as the Senior Vice President of Solutions & Services at DNAnexus, a position he has held since 2023. In this role, he focuses on providing custom support, utilizing his expertise in bioinformatics and genetic analysis. His responsibilities include overseeing the development and implementation of solutions that meet client needs in the field of genomic data analysis.
Previous Experience at GSK
Prior to his current position, Matt Newman worked at GlaxoSmithKline (GSK) as an Associate Scientist from 2004 to 2008. During his four years at GSK, he contributed to various projects within the pharmaceutical sector, applying his knowledge in biochemistry and molecular biology to advance research initiatives.
Career at QIAGEN
Matt Newman held the position of Vice President of Business Development and Professional Services at QIAGEN from 2019 to 2022. Based in the Sarasota, Florida area, he was responsible for driving business growth and enhancing service offerings, leveraging his extensive background in bioinformatics and genetic analysis.
Educational Background
Matt Newman earned his Bachelor's degree in Biochemistry and Molecular Biology from Penn State University, where he studied from 1997 to 2002. His education provided a strong foundation in the biological sciences, which he has applied throughout his career in various roles within the biotechnology and pharmaceutical industries.
Expertise in Bioinformatics
Matt Newman possesses specialized expertise in bioinformatics software, genetic analysis, gene expression analysis, and microarray analysis. His skills enable him to contribute effectively to projects involving complex genomic data, supporting advancements in personalized medicine and research.